Article Details

I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody ...

Retrieved on: 2020-11-08 21:07:30

Tags for this article:

Click the tags to see associated articles and topics

I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody .... View article details on HISWAI:

Excerpt

<div>Lemzoparlimab is a unique CD47 <b>antibody</b> that exerts strong anti-tumor activity while exhibiting a minimal binding to red blood cells. It is designed to ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up